美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Therapeutics

39.27

+0.02000.05%

盘后：39.270.00000.00%19:02 EDT

成交量：55.12万

成交额：2,154.10万

市值：11.20亿

市盈率：-20.69

高：40.35

开：39.27

低：38.41

收：39.25

52周最高：41.70

52周最低：16.54

股本：2,852.21万

流通股本：1,313.48万

量比：1.23

换手率：4.20%

股息：- -

股息率：- -

每股收益(TTM):-1.8984

每股收益(LYR):-2.3387

净资产收益率：-26.25%

总资产收益率：-18.44%

市净率：5.43

市盈率(LYR):-16.79

数据加载中...

总览公司新闻公告

Tg Therapeutics, Inc.8月18日成交额为6641.31万美元

Bioxcel Therapeutics, Inc.8月18日成交额为2.21亿美元

Aligos Therapeutics, Inc.盘中异动早盘大幅拉升7.27%

Unicycive Therapeutics, Inc.盘中异动快速跳水5.00%

Karyopharm Therapeutics Inc.2025财年第二财季实现净利润-37.25百万美元，同比减少256.58%

Trevi Therapeutics, Inc.2025财年第二财季实现净利润-12.30百万美元，同比增加0.40%

Relay Therapeutics, Inc.盘中异动快速上涨5.01%

CRISPR Therapeutics（CRSP）涨幅迅速扩大至3.4%。

Voyager Therapeutics, Inc.2025财年第二财季实现净利润-33.38百万美元，同比减少229.19%

Monte Rosa Therapeutics, Inc.盘中异动临近午盘股价大涨5.06%报4.57美元

Tg Therapeutics, Inc.8月14日成交额为4634.66万美元

Summit Therapeutics Inc.8月12日成交额为1.66亿美元

Zevra Therapeutics因业绩大幅低于预期而股价下跌，尽管收入超预期

Unicycive Therapeutics, Inc.盘中异动下午盘股价大涨5.08%报4.21美元

Black Diamond Therapeutics, Inc.盘中异动早盘急速拉升5.19%

Windtree Therapeutics, Inc.8月11日成交额为72.30万美元

Vyne Therapeutics Inc.8月11日成交额为69.37万美元

美股财报 | Kymera Therapeutics发布Q2财报前半年累计净亏损同比扩大56.92%

Larimar Therapeutics, Inc.8月11日成交额为496.75万美元

Entero Therapeutics Inc.8月11日成交额为1.98亿美元

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/LENZ/news?page=3"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LENZ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LENZ\",,,,,undefined,":{"symbol":"LENZ","market":"US","secType":"STK","nameCN":"Therapeutics","latestPrice":39.27,"timestamp":1756929600000,"preClose":39.25,"halted":0,"volume":551197,"hourTrading":{"tag":"盘后","latestPrice":39.27,"preClose":39.27,"latestTime":"19:02 EDT","volume":24003,"amount":942518.41,"timestamp":1756940522150},"delay":0,"floatShares":13134810,"shares":28522096,"eps":-1.898372,"marketStatus":"未开盘","change":0.02,"latestTime":"09-03 16:00:00 EDT","open":39.27,"high":40.35,"low":38.41,"amount":21540956.245434,"amplitude":0.049427,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.898372,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1756972800000},"marketStatusCode":0,"adr":0,"listingDate":1624593600000,"exchange":"NASDAQ","adjPreClose":39.25,"preHourTrading":{"tag":"盘前","latestPrice":39.5,"preClose":39.25,"latestTime":"09:28 EDT","volume":203,"amount":8034.22032,"timestamp":1756906080020},"postHourTrading":{"tag":"盘后","latestPrice":39.27,"preClose":39.27,"latestTime":"19:02 EDT","volume":24003,"amount":942518.41,"timestamp":1756940522150},"volumeRatio":1.225562,"impliedVol":0.8002,"impliedVolPercentile":0.6436},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LENZ\",,,,,undefined,":{"symbol":"LENZ","floatShares":13134810,"roa":"-18.44%","roe":"-26.25%","lyrEps":-2.338654,"volumeRatio":1.225562,"shares":28522096,"dividePrice":0,"high":40.35,"amplitude":0.049427,"preClose":39.25,"low":38.41,"week52Low":16.535,"pbRate":"5.43","psRate":"224.01","week52High":41.7,"institutionHeld":0,"latestPrice":39.27,"eps":-1.898372,"divideRate":0,"volume":551197,"delay":0,"ttmEps":-1.898372,"open":39.27,"prevYearClose":28.87,"prevWeekClose":38.63,"prevMonthClose":38.63,"prevQuarterClose":29.31,"fiveDayClose":38.64,"twentyDayClose":30.48,"sixtyDayClose":31.96},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LENZ\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-07-30","symbol":"LENZ","fiscalQuarterEnding":"2025/06","expectedEps":-0.58,"name":null,"time":"盘前","type":"earning","dateTimestamp":1753848000000,"reportTimeType":"pre","actualEps":-0.53},{"market":"US","date":"2024-05-08","symbol":"LENZ","fiscalQuarterEnding":"2024/03","expectedEps":-0.84,"name":null,"time":"盘前","type":"earning","dateTimestamp":1715140800000,"reportTimeType":"pre","actualEps":-3.53},{"market":"US","date":"2024-03-22","symbol":"LENZ","defaultRemindTime":1711114200000,"type":"split","dateTimestamp":1711080000000,"forFactor":7,"toFactor":1,"ratio":7},{"date":"2024-03-22","symbol":"LENZ","amount":1.03,"announcedDate":null,"type":"dividend","market":"US","newRecordDate":"2024-03-18","name":"Therapeutics","recordDate":"2024-03-21","payableDate":"2024-03-18","currency":"USD","dateTimestamp":1711080000000,"payDate":"2024-03-21"},{"market":"US","date":"2021-08-12","symbol":"LENZ","fiscalQuarterEnding":"2021/06","expectedEps":-1.11,"name":null,"time":"","type":"earning","dateTimestamp":1628740800000,"reportTimeType":"","actualEps":-3.45}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LENZ\",market:\"US\",,,undefined,":[{"executeDate":"2024-03-22","recordDate":"2024-03-18","paymentDate":"2024-03-21","value":1.03,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LENZ\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":8,"updateTime":1742270400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LENZ\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LENZ","date":"2025-09-02","current":-21.027684,"percent":0.02346,"low":-22.268769,"twenty":-16.632408,"median":-11.242944,"eighty":-7.781071,"high":-5.069183,"avg":-12.141756,"sd":4.57973,"marketCap":1101808568},"quantilePoints":[{"date":"2024-03-28","current":-7.959158,"twenty":-7.219077,"median":-6.108955,"eighty":-6.016992,"marketCap":556886354},{"date":"2024-04-05","current":-7.492045,"twenty":-7.873034,"median":-7.667213,"eighty":-6.662191,"marketCap":524203432},{"date":"2024-04-12","current":-7.929963,"twenty":-7.855517,"median":-7.667213,"eighty":-7.432197,"marketCap":554843672},{"date":"2024-04-19","current":-6.382653,"twenty":-7.855517,"median":-7.488396,"eighty":-6.783348,"marketCap":446581492},{"date":"2024-04-26","current":-5.638193,"twenty":-7.716113,"median":-7.451903,"eighty":-5.889996,"marketCap":394493084},{"date":"2024-05-03","current":-5.988527,"twenty":-7.671592,"median":-6.864363,"eighty":-5.803142,"marketCap":419005276},{"date":"2024-05-10","current":-5.317808,"twenty":-7.667213,"median":-6.108955,"eighty":-5.803142,"marketCap":393230653},{"date":"2024-05-17","current":-5.708011,"twenty":-7.597146,"median":-6.0013,"eighty":-5.749862,"marketCap":422084590},{"date":"2024-05-24","current":-5.428308,"twenty":-7.489126,"median":-6.006774,"eighty":-5.719496,"marketCap":401401679},{"date":"2024-05-31","current":-5.355793,"twenty":-7.479638,"median":-5.988527,"eighty":-5.522773,"marketCap":396039443},{"date":"2024-06-07","current":-5.193496,"twenty":-7.457742,"median":-5.904593,"eighty":-5.428999,"marketCap":384038248},{"date":"2024-06-14","current":-6.433167,"twenty":-7.451903,"median":-5.930138,"eighty":-5.428308,"marketCap":475706952},{"date":"2024-06-21","current":-6.236339,"twenty":-7.425628,"median":-5.992177,"eighty":-5.43107,"marketCap":461152311},{"date":"2024-06-28","current":-6.150011,"twenty":-7.389135,"median":-6.0013,"eighty":-5.439358,"marketCap":454768696},{"date":"2024-07-05","current":-6.098214,"twenty":-7.269437,"median":-6.014073,"eighty":-5.469746,"marketCap":450938528},{"date":"2024-07-12","current":-6.771573,"twenty":-6.771573,"median":-6.098214,"eighty":-5.493918,"marketCap":500730721},{"date":"2024-07-15","current":-7.261916,"twenty":-7.163847,"median":-6.103393,"eighty":-5.509112,"marketCap":536989651},{"date":"2024-08-02","current":-8.498134,"twenty":-7.266429,"median":-6.108573,"eighty":-5.524305,"marketCap":628403011},{"date":"2024-08-09","current":-8.328931,"twenty":-7.474529,"median":-6.146558,"eighty":-5.597209,"marketCap":615891126},{"date":"2024-08-16","current":-8.944708,"twenty":-7.671592,"median":-6.236339,"eighty":-5.641258,"marketCap":621424629},{"date":"2024-08-23","current":-8.79431,"twenty":-7.94748,"median":-6.352018,"eighty":-5.670717,"marketCap":610975896},{"date":"2024-08-30","current":-8.746816,"twenty":-8.006409,"median":-6.382653,"eighty":-5.719496,"marketCap":607676296},{"date":"2024-09-06","current":-9.451311,"twenty":-8.199004,"median":-6.419354,"eighty":-5.743293,"marketCap":656620360},{"date":"2024-09-13","current":-8.17293,"twenty":-8.352945,"median":-6.434893,"eighty":-5.773217,"marketCap":567806132},{"date":"2024-09-20","current":-8.7389,"twenty":-8.507104,"median":-6.459289,"eighty":-5.788545,"marketCap":607126363},{"date":"2024-09-27","current":-8.806184,"twenty":-8.638371,"median":-6.616182,"eighty":-5.792924,"marketCap":611800796},{"date":"2024-10-04","current":-8.897214,"twenty":-8.745233,"median":-7.269437,"eighty":-5.800953,"marketCap":618125029},{"date":"2024-10-11","current":-9.340491,"twenty":-8.850511,"median":-7.455552,"eighty":-5.81701,"marketCap":648921294},{"date":"2024-10-18","current":-10.417023,"twenty":-8.905129,"median":-7.492045,"eighty":-5.857882,"marketCap":723712222},{"date":"2024-10-25","current":-9.902504,"twenty":-9.0017,"median":-7.670862,"eighty":-5.904593,"marketCap":687966558},{"date":"2024-10-31","current":-10.939457,"twenty":-9.257377,"median":-7.718702,"eighty":-5.904593,"marketCap":760007820},{"date":"2024-11-08","current":-14.709443,"twenty":-9.419648,"median":-7.959158,"eighty":-5.955683,"marketCap":894466512},{"date":"2024-11-15","current":-15.344855,"twenty":-9.514636,"median":-8.00261,"eighty":-5.970448,"marketCap":933105265},{"date":"2024-11-22","current":-15.521232,"twenty":-9.76398,"median":-8.132103,"eighty":-5.988527,"marketCap":943830613},{"date":"2024-11-29","current":-16.100113,"twenty":-9.924668,"median":-8.17293,"eighty":-5.994366,"marketCap":979031755},{"date":"2024-12-06","current":-16.33076,"twenty":-10.388526,"median":-8.285117,"eighty":-6.004584,"marketCap":993057210},{"date":"2024-12-13","current":-13.920266,"twenty":-10.815972,"median":-8.351032,"eighty":-6.018452,"marketCap":846477455},{"date":"2024-12-20","current":-13.694141,"twenty":-11.182468,"median":-8.50374,"eighty":-6.082845,"marketCap":832727009},{"date":"2024-12-27","current":-14.476534,"twenty":-12.093039,"median":-8.531114,"eighty":-6.098214,"marketCap":880303552},{"date":"2025-01-03","current":-12.794163,"twenty":-13.449021,"median":-8.618187,"eighty":-6.102358,"marketCap":778000234},{"date":"2025-01-10","current":-11.912274,"twenty":-13.190334,"median":-8.707238,"eighty":-6.108649,"marketCap":724373495},{"date":"2025-01-17","current":-10.130408,"twenty":-13.019383,"median":-8.746816,"eighty":-6.115785,"marketCap":616019980},{"date":"2025-01-24","current":-11.197719,"twenty":-12.871045,"median":-8.79431,"eighty":-6.143105,"marketCap":680922085},{"date":"2025-01-31","current":-11.523339,"twenty":-12.794163,"median":-8.877425,"eighty":-6.150011,"marketCap":700722728},{"date":"2025-02-07","current":-12.070562,"twenty":-12.328345,"median":-8.905129,"eighty":-6.232886,"marketCap":733998807},{"date":"2025-02-14","current":-11.432889,"twenty":-12.292165,"median":-8.964497,"eighty":-6.236339,"marketCap":695222549},{"date":"2025-02-21","current":-11.279124,"twenty":-12.151063,"median":-8.998138,"eighty":-6.308164,"marketCap":685872246},{"date":"2025-02-28","current":-9.62841,"twenty":-12.079607,"median":-9.059485,"eighty":-6.342695,"marketCap":585493990},{"date":"2025-03-07","current":-10.297741,"twenty":-11.943932,"median":-9.320702,"eighty":-6.355126,"marketCap":626195310},{"date":"2025-03-14","current":-11.193196,"twenty":-11.879712,"median":-9.419648,"eighty":-6.365485,"marketCap":680647077},{"date":"2025-03-21","current":-14.554795,"twenty":-11.943932,"median":-9.482973,"eighty":-6.379634,"marketCap":724377586},{"date":"2025-03-28","current":-14.68208,"twenty":-12.421509,"median":-9.574004,"eighty":-6.398202,"marketCap":730712447},{"date":"2025-04-04","current":-12.728528,"twenty":-13.089934,"median":-9.668992,"eighty":-6.415901,"marketCap":633486102},{"date":"2025-04-11","current":-10.2603,"twenty":-12.90813,"median":-9.741473,"eighty":-6.42488,"marketCap":510644883},{"date":"2025-04-17","current":-12.761733,"twenty":-12.945214,"median":-9.779811,"eighty":-6.430405,"marketCap":635138674},{"date":"2025-04-25","current":-15.833323,"twenty":-13.271407,"median":-9.84549,"eighty":-6.435239,"marketCap":788008663},{"date":"2025-05-02","current":-15.982746,"twenty":-13.932929,"median":-9.940463,"eighty":-6.440764,"marketCap":795445305},{"date":"2025-05-09","current":-15.25222,"twenty":-14.136351,"median":-10.102399,"eighty":-6.452984,"marketCap":728141003},{"date":"2025-05-16","current":-16.118891,"twenty":-14.245886,"median":-10.138549,"eighty":-6.460191,"marketCap":769515850},{"date":"2025-05-23","current":-16.637714,"twenty":-14.356129,"median":-10.19625,"eighty":-6.460792,"marketCap":794284465},{"date":"2025-05-30","current":-17.410053,"twenty":-14.523491,"median":-10.236057,"eighty":-6.585104,"marketCap":831155927},{"date":"2025-06-06","current":-17.864023,"twenty":-14.65894,"median":-10.342966,"eighty":-6.96771,"marketCap":852828466},{"date":"2025-06-13","current":-17.439532,"twenty":-14.747436,"median":-10.384797,"eighty":-7.264924,"marketCap":832563235},{"date":"2025-06-20","current":-17.704839,"twenty":-14.88454,"median":-10.454615,"eighty":-7.299361,"marketCap":845229004},{"date":"2025-06-27","current":-17.752005,"twenty":-15.005667,"median":-10.623361,"eighty":-7.425628,"marketCap":847480696},{"date":"2025-07-03","current":-19.178768,"twenty":-15.33581,"median":-10.694071,"eighty":-7.451903,"marketCap":915594389},{"date":"2025-07-11","current":-20.198727,"twenty":-15.529319,"median":-10.766979,"eighty":-7.459202,"marketCap":964287236},{"date":"2025-07-18","current":-20.381494,"twenty":-15.833323,"median":-10.791578,"eighty":-7.484747,"marketCap":973012543},{"date":"2025-07-25","current":-19.691695,"twenty":-16.100113,"median":-11.044571,"eighty":-7.492045,"marketCap":940081543},{"date":"2025-08-01","current":-16.20487,"twenty":-16.158905,"median":-11.077981,"eighty":-7.667213,"marketCap":849102797},{"date":"2025-08-08","current":-17.484059,"twenty":-16.20487,"median":-11.141188,"eighty":-7.667213,"marketCap":916129723},{"date":"2025-08-15","current":-22.268769,"twenty":-16.33076,"median":-11.193196,"eighty":-7.674511,"marketCap":1166838947},{"date":"2025-08-22","current":-21.691773,"twenty":-16.434778,"median":-11.220775,"eighty":-7.693556,"marketCap":1136605525},{"date":"2025-08-29","current":-20.793619,"twenty":-16.611183,"median":-11.233899,"eighty":-7.743848,"marketCap":1089544067},{"date":"2025-09-02","current":-21.027684,"twenty":-16.632408,"median":-11.242944,"eighty":-7.781071,"marketCap":1101808568}],"updateTime":1756960764296},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LENZ\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2560128372","title":"Tg Therapeutics, Inc.8月18日成交额为6641.31万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2560128372","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560128372?lang=zh_cn&edition=fundamental","pubTime":"2025-08-19 15:46","pubTimestamp":1755589572,"startTime":"0","endTime":"0","summary":"美东时间2025年8月18日，Tg Therapeutics, Inc.成交额为6641.31万美元，成交额较昨日增加30.88%，当日成交量为235.77万股。Tg Therapeutics, Inc.于2025年8月18日跌1.25%，报27.73美元，该股过去5个交易日涨5.08%，年初至今跌7.87%，过去60日跌18.92%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-18|6641.31万|30.88%|235.77万|#|2025-08-15|5074.52万|9.49%|181.20万|#|2025-08-14|4634.66万|-38.07%|166.85万|#|2025-08-13|7484.11万|22.13%|269.62万|#|2025-08-12|6127.93万|-49.29%|229.86万|TG Therapeutics Inc 是一家完全整合的商业化生物制药公司，专注于 B 细胞疾病新疗法的收购、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250819160550a49156a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250819160550a49156a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4539","BK4139","LENZ"],"gpt_icon":0},{"id":"2560621192","title":"Bioxcel Therapeutics, Inc.8月18日成交额为2.21亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2560621192","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560621192?lang=zh_cn&edition=fundamental","pubTime":"2025-08-19 09:31","pubTimestamp":1755567069,"startTime":"0","endTime":"0","summary":"美东时间2025年8月18日，Bioxcel Therapeutics, Inc.成交额为2.21亿美元，成交额较昨日增加392.70%，当日成交量为3589.32万股。Bioxcel Therapeutics, Inc.于2025年8月18日涨3.47%，报5.67美元，该股过去5个交易日跌11.41%，年初至今跌5.25%，过去60日涨307.91%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-18|2.21亿|392.70%|3589.32万|#|2025-08-15|4492.08万|1.20%|926.57万|#|2025-08-14|4438.86万|-54.47%|832.62万|#|2025-08-13|9749.73万|-59.23%|1552.41万|#|2025-08-12|2.39亿|0.87%|3558.36万|BioXcel Therapeutics Inc 是一家处于临床阶段的生物制药公司。公司的管线产品有 BXCL501 和 BXCL701。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250819093643a490a422&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250819093643a490a422&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4539","BK4139","LENZ"],"gpt_icon":0},{"id":"2560082155","title":"Aligos Therapeutics, Inc.盘中异动 早盘大幅拉升7.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2560082155","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560082155?lang=zh_cn&edition=fundamental","pubTime":"2025-08-18 23:07","pubTimestamp":1755529672,"startTime":"0","endTime":"0","summary":"北京时间2025年08月18日23时07分，Aligos Therapeutics, Inc.股票出现波动，股价大幅上涨7.27%。截至发稿，该股报8.26美元/股，成交量2.0424万股，换手率0.29%，振幅5.30%。Aligos Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.52%。其相关个股中，Soligenix, Inc.、Propanc Biopharma, Inc.、Aspire Biopharma Holdings, Inc.涨幅较大，Soligenix, Inc.、Aspire Biopharma Holdings, Inc.、Propanc Biopharma, Inc.较为活跃，换手率分别为3022.09%、753.76%、435.30%，振幅较大的相关个股有Propanc Biopharma, Inc.、Soligenix, Inc.、Aspire Biopharma Holdings, Inc.，振幅分别为128.92%、95.66%、83.57%。Aligos Therapeutics, Inc.公司简介：Aligos Therapeutics Inc 是一家临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250818230752a6ed43fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250818230752a6ed43fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALGS","BK4007","BK4505","LENZ","BK4539","BK4139"],"gpt_icon":0},{"id":"2560138420","title":"Unicycive Therapeutics, Inc.盘中异动 快速跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2560138420","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560138420?lang=zh_cn&edition=fundamental","pubTime":"2025-08-18 21:33","pubTimestamp":1755524037,"startTime":"0","endTime":"0","summary":"北京时间2025年08月18日21时33分，Unicycive Therapeutics, Inc.股票出现异动，股价快速下跌5.00%。Unicycive Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。其相关个股中，Propanc Biopharma, Inc.、Aspire Biopharma Holdings, Inc.、Adaptimmune Therapeutics Plc涨幅较大，Soligenix, Inc.、Aspire Biopharma Holdings, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为980.75%、208.27%、129.56%，振幅较大的相关个股有Propanc Biopharma, Inc.、Immunoprecise Antibodies Ltd.、Aspire Biopharma Holdings, Inc.，振幅分别为39.02%、32.42%、27.47%。Unicycive Therapeutics, Inc.公司简介：Unicycive Therapeutics Inc是一家致力于开发某些医疗条件治疗方法的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250818213357a48fc4eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250818213357a48fc4eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","LENZ","BK4007","UNCY"],"gpt_icon":0},{"id":"2560976359","title":"Karyopharm Therapeutics Inc.2025财年第二财季实现净利润-37.25百万美元，同比减少256.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2560976359","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560976359?lang=zh_cn&edition=fundamental","pubTime":"2025-08-18 00:00","pubTimestamp":1755446446,"startTime":"0","endTime":"0","summary":"8月18日，Karyopharm Therapeutics Inc.公布财报，公告显示公司2025财年第二财季净利润为-37.25百万美元，同比减少256.58%；其中营业收入为37.93百万美元，同比减少11.36%，每股基本收益为-4.32美元。机构评级：截至2025年8月18日，当前有6家机构对Karyopharm Therapeutics Inc.目标价做出预测，其中目标均价为19.17美元，其中最低目标价为8.00美元，最高目标价为30.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250818000141a6eb4d65&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250818000141a6eb4d65&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KPTI","LENZ"],"gpt_icon":0},{"id":"2560921224","title":"Trevi Therapeutics, Inc.2025财年第二财季实现净利润-12.30百万美元，同比增加0.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2560921224","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560921224?lang=zh_cn&edition=fundamental","pubTime":"2025-08-17 00:02","pubTimestamp":1755360148,"startTime":"0","endTime":"0","summary":"8月17日，Trevi Therapeutics, Inc.公布财报，公告显示公司2025财年第二财季净利润为-12.30百万美元，同比增加0.40%；其中营业收入为0.00美元，每股基本收益为-0.09美元。从资产负债表来看，Trevi Therapeutics, Inc.总负债9.85百万美元，其中短期债务286000.00美元，资产负债比为0.22，流动比率为0.23。机构评级：截至2025年8月17日，当前有11家机构对Trevi Therapeutics, Inc.目标价做出预测，其中目标均价为19.73美元，其中最低目标价为11.00美元，最高目标价为27.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250817000528a48ca16c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250817000528a48ca16c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ"],"gpt_icon":0},{"id":"2559536946","title":"Relay Therapeutics, Inc.盘中异动 快速上涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2559536946","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559536946?lang=zh_cn&edition=fundamental","pubTime":"2025-08-16 00:54","pubTimestamp":1755276881,"startTime":"0","endTime":"0","summary":"北京时间2025年08月16日00时54分，Relay Therapeutics, Inc.股票出现波动，股价快速拉升5.01%。Relay Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.32%。Relay Therapeutics, Inc.公司简介：Relay Therapeutics Inc 是一家临床阶段的精准医疗公司，通过结合领先的计算和实验技术来转变药物发现过程，旨在为患者带来改变生命的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081600544194e60336&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081600544194e60336&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","RLAY","BK4563","LENZ","BK4007"],"gpt_icon":0},{"id":"2559489809","title":"CRISPR Therapeutics（CRSP）涨幅迅速扩大至3.4%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2559489809","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559489809?lang=zh_cn&edition=fundamental","pubTime":"2025-08-16 00:42","pubTimestamp":1755276177,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","BK4007","BK4611","BK4588","CRSP","LENZ","BK4556","BK4139","LU1861559042.SGD","LU1861558580.USD","BK4539"],"gpt_icon":0},{"id":"2559947460","title":"Voyager Therapeutics, Inc.2025财年第二财季实现净利润-33.38百万美元，同比减少229.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2559947460","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559947460?lang=zh_cn&edition=fundamental","pubTime":"2025-08-16 00:00","pubTimestamp":1755273621,"startTime":"0","endTime":"0","summary":"8月16日，Voyager Therapeutics, Inc.公布财报，公告显示公司2025财年第二财季净利润为-33.38百万美元，同比减少229.19%；其中营业收入为5.20百万美元，同比减少82.42%，每股基本收益为-0.57美元。机构评级：截至2025年8月16日，当前有9家机构对Voyager Therapeutics, Inc.目标价做出预测，其中目标均价为15.67美元，其中最低目标价为8.00美元，最高目标价为30.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250816000048a6e89cbf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250816000048a6e89cbf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ"],"gpt_icon":0},{"id":"2559952923","title":"Monte Rosa Therapeutics, Inc.盘中异动 临近午盘股价大涨5.06%报4.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2559952923","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559952923?lang=zh_cn&edition=fundamental","pubTime":"2025-08-15 23:35","pubTimestamp":1755272139,"startTime":"0","endTime":"0","summary":"北京时间2025年08月15日23时35分，Monte Rosa Therapeutics, Inc.股票出现波动，股价快速上涨5.06%。Monte Rosa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.72%。Monte Rosa Therapeutics, Inc.公司简介：Monte Rosa Therapeutics Inc是一家生物技术公司，专门开发分子胶降解剂，这是一类利用人体天然蛋白质破坏机制选择性降解治疗相关蛋白质的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250815233539a6e8958b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250815233539a6e8958b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","GLUE","BK4539","LENZ","BK4139"],"gpt_icon":0},{"id":"2559944027","title":"Tg Therapeutics, Inc.8月14日成交额为4634.66万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2559944027","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559944027?lang=zh_cn&edition=fundamental","pubTime":"2025-08-15 15:45","pubTimestamp":1755243914,"startTime":"0","endTime":"0","summary":"美东时间2025年8月14日，Tg Therapeutics, Inc.成交额为4634.66万美元，成交额较昨日减少38.07%，当日成交量为166.85万股。Tg Therapeutics, Inc.于2025年8月14日跌0.36%，报27.77美元，该股过去5个交易日跌0.43%，年初至今跌7.74%，过去60日跌20.61%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-14|4634.66万|-38.07%|166.85万|#|2025-08-13|7484.11万|22.13%|269.62万|#|2025-08-12|6127.93万|-49.29%|229.86万|#|2025-08-11|1.21亿|-6.80%|456.21万|#|2025-08-08|1.30亿|86.39%|479.98万|TG Therapeutics Inc 是一家完全整合的商业化生物制药公司，专注于 B 细胞疾病新疗法的收购、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250815160652a6e7cc0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250815160652a6e7cc0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2559098696","title":"Summit Therapeutics Inc.8月12日成交额为1.66亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2559098696","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559098696?lang=zh_cn&edition=fundamental","pubTime":"2025-08-13 14:46","pubTimestamp":1755067599,"startTime":"0","endTime":"0","summary":"美东时间2025年8月12日，Summit Therapeutics Inc.成交额为1.66亿美元，成交额较昨日增加206.15%，当日成交量为650.57万股。Summit Therapeutics Inc.于2025年8月12日跌9.08%，报25.69美元，该股过去5个交易日跌11.83%，年初至今涨43.89%，过去60日涨11.24%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-12|1.66亿|206.15%|650.57万|#|2025-08-11|5429.00万|-1.65%|190.17万|#|2025-08-08|5519.87万|15.21%|192.31万|#|2025-08-07|4791.13万|-24.99%|171.86万|#|2025-08-06|6387.04万|-44.62%|223.96万|Summit Therapeutics Inc是一家生物制药公司，专注于发现、开发和商业化用于严重传染病的新型抗生素。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250813144641a485b933&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250813144641a485b933&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","BK4539","LENZ"],"gpt_icon":0},{"id":"2559621711","title":"Zevra Therapeutics因业绩大幅低于预期而股价下跌，尽管收入超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2559621711","media":"英为财情","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559621711?lang=zh_cn&edition=fundamental","pubTime":"2025-08-13 04:31","pubTimestamp":1755030660,"startTime":"0","endTime":"0","summary":"Investing.com -- Zevra Therapeutics, Inc. 公布的第二季度收入超过分析师预期，但由于该罕见疾病专注公司的盈利大幅低于预期，股价下跌了3%。Zevra的收入主要来自MIPLYFFA的2150万美元净销售额，这是其治疗尼曼-匹克病C型的药物，该药物于去年年底获得批准。公司报告本季度有7份新的MIPLYFFA处方登记表，使自上市以来的总数达到129份，市场准入覆盖了52%的受保人群。截至2025年6月30日，Zevra季末现金状况强劲，达2.177亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://cn.investing.com/news/earnings/article-93CH-2934132","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investing_news","symbols":["ZVRA","BK4539","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2559275646","title":"Unicycive Therapeutics, Inc.盘中异动 下午盘股价大涨5.08%报4.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2559275646","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559275646?lang=zh_cn&edition=fundamental","pubTime":"2025-08-13 01:59","pubTimestamp":1755021580,"startTime":"0","endTime":"0","summary":"北京时间2025年08月13日01时59分，Unicycive Therapeutics, Inc.股票出现波动，股价急速拉升5.08%。Unicycive Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.80%。Unicycive Therapeutics, Inc.公司简介：Unicycive Therapeutics Inc是一家致力于开发某些医疗条件治疗方法的生物技术公司。Unicycive的另一种药物UNI-494是一种新的化学实体，已获得物质成分专利保护，处于临床前开发后期，用于治疗急性肾损伤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250813015941a4849455&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250813015941a4849455&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","UNCY","LENZ","BK4007"],"gpt_icon":0},{"id":"2559662649","title":"Black Diamond Therapeutics, Inc.盘中异动 早盘急速拉升5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2559662649","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559662649?lang=zh_cn&edition=fundamental","pubTime":"2025-08-12 21:30","pubTimestamp":1755005432,"startTime":"0","endTime":"0","summary":"北京时间2025年08月12日21时30分，Black Diamond Therapeutics, Inc.股票出现异动，股价急速上涨5.19%。Black Diamond Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，180 Life Sciences Corp C/Wts 07/11/2025、180 Life Sciences Corp.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Tnf Pharmaceuticals, Inc.、X4制药、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为737.54%、443.11%、71.46%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Tuhura Biosciences, Inc.、Relmada Therapeutics, Inc.，振幅分别为13.57%、11.64%、10.83%。Black Diamond Therapeutics, Inc.公司简介：Black Diamond Therapeutics Inc 是一家临床阶段的肿瘤学公司，开发针对癌症患者致癌突变家族的 MasterKey 疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081221303297431b9d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081221303297431b9d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BDTX","BK4539","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2558648953","title":"Windtree Therapeutics, Inc.8月11日成交额为72.30万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558648953","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558648953?lang=zh_cn&edition=fundamental","pubTime":"2025-08-12 16:30","pubTimestamp":1754987401,"startTime":"0","endTime":"0","summary":"美东时间2025年8月11日，Windtree Therapeutics, Inc.成交额为72.30万美元，成交额较昨日减少24.31%，当日成交量为131.23万股。Windtree Therapeutics, Inc.于2025年8月11日跌0.26%，报0.546美元，该股过去5个交易日跌6.22%，年初至今跌96.87%，过去60日跌37.26%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-11|72.30万|-24.31%|131.23万|#|2025-08-08|95.53万|26.99%|171.15万|#|2025-08-07|75.22万|-58.11%|133.51万|#|2025-08-06|179.59万|4.64%|329.28万|#|2025-08-05|171.63万|-14.11%|318.42万|Windtree Therapeutics Inc 是一家生物技术公司，专注于推进针对危重疾病和疾病的早期和晚期疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812171651a6e15dcc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812171651a6e15dcc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["WINT","LENZ","BK4007","WINTW","BK4139","BK4539"],"gpt_icon":0},{"id":"2558864893","title":"Vyne Therapeutics Inc.8月11日成交额为69.37万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558864893","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558864893?lang=zh_cn&edition=fundamental","pubTime":"2025-08-12 16:17","pubTimestamp":1754986657,"startTime":"0","endTime":"0","summary":"美东时间2025年8月11日，Vyne Therapeutics Inc.成交额为69.37万美元，成交额较昨日减少27.88%，当日成交量为202.93万股。Vyne Therapeutics Inc.于2025年8月11日跌4.48%，报0.341美元，该股过去5个交易日跌6.6%，年初至今跌89.82%，过去60日跌72.94%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-11|69.37万|-27.88%|202.93万|#|2025-08-08|96.19万|-45.20%|271.51万|#|2025-08-07|175.54万|64.64%|467.26万|#|2025-08-06|106.62万|-41.00%|294.79万|#|2025-08-05|180.73万|24.73%|483.15万|VYNE Therapeutics Inc 是一家生物制药公司，专注于开发用于治疗免疫炎症的专有、创新和差异化疗法。其产品包括 AMZEEQ、ZILXI 和 FCD105。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812171237a6e15b36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812171237a6e15b36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","VYNE","BK4139","BK4007","BK4539"],"gpt_icon":0},{"id":"2558618200","title":"美股财报 | Kymera Therapeutics发布Q2财报 前半年累计净亏损同比扩大56.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558618200","media":"同花顺iNews","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558618200?lang=zh_cn&edition=fundamental","pubTime":"2025-08-12 12:00","pubTimestamp":1754971213,"startTime":"0","endTime":"0","summary":"kymera therapeutics(KYMR)发布Q2财报，2025财年前六月累计收入3357.60万美元，去年同期累计收入为3593.70万美元，同比减少6.57%。2025财年前六月累计净亏损1.42亿美元，去年同期累计净亏损为9061.90万美元，同比扩大56.92%。本财年累计基本每股收益为-1.77美元，去年同期为-1.26美元。公司所属行业为生物科技。【公司信息】kymera therapeutics, Inc.，一家根据特拉华州法律于2017年5月25日成立的有限责任公司。该公司是一家生物制药公司，致力于发现和开发新颖的小分子疗法，该疗法可通过利用药物选择性地降解致病蛋白。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812120534a48334f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812120534a48334f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KYMR","LENZ"],"gpt_icon":0},{"id":"2558761820","title":"Larimar Therapeutics, Inc.8月11日成交额为496.75万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558761820","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558761820?lang=zh_cn&edition=fundamental","pubTime":"2025-08-12 11:52","pubTimestamp":1754970775,"startTime":"0","endTime":"0","summary":"美东时间2025年8月11日，Larimar Therapeutics, Inc.成交额为496.75万美元，成交额较昨日增加16.56%，当日成交量为134.64万股。Larimar Therapeutics, Inc.于2025年8月11日涨5.59%，报3.78美元，该股过去5个交易日涨14.2%，年初至今跌2.33%，过去60日涨111.17%。其主打候选产品 CTI-1601 是一种皮下注射的重组融合蛋白，旨在将人类铁硫蛋白这种必需蛋白递送至弗里德赖希共济失调症患者的线粒体中。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812115301a6e0ca68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812115301a6e0ca68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LRMR","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2558697985","title":"Entero Therapeutics Inc.8月11日成交额为1.98亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558697985","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558697985?lang=zh_cn&edition=fundamental","pubTime":"2025-08-12 10:13","pubTimestamp":1754964797,"startTime":"0","endTime":"0","summary":"美东时间2025年8月11日，Entero Therapeutics Inc.成交额为1.98亿美元，成交额较昨日增加325996.83%，当日成交量为3.02亿股。Entero Therapeutics Inc.于2025年8月11日涨66.46%，报0.607美元，该股过去5个交易日涨42.92%，年初至今跌2.35%，过去60日涨45.31%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-08-11|1.98亿|325996.83%|3.02亿|#|2025-08-08|6.07万|-9.15%|16.12万|#|2025-08-07|6.68万|-57.85%|16.99万|#|2025-08-06|15.85万|1538.90%|36.07万|#|2025-08-05|9671.00|-41.14%|2.29万|Entero Therapeutics Inc 是一家后期临床阶段的生物制药公司，专注于开发针对胃肠道疾病的靶向非全身性治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812101323a4830097&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812101323a4830097&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","ENTO","BK4007","BK4139","LENZ"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":197,"code":"91000000","status":"200"}]}}